Published in Clin Infect Dis on October 04, 2000
Hand, foot, and mouth disease in China, 2008-12: an epidemiological study. Lancet Infect Dis (2014) 6.80
Epidemic hand, foot and mouth disease caused by human enterovirus 71, Singapore. Emerg Infect Dis (2003) 3.98
An emerging recombinant human enterovirus 71 responsible for the 2008 outbreak of hand foot and mouth disease in Fuyang city of China. Virol J (2010) 3.90
Phylogenetic analysis of enterovirus 71 strains isolated during linked epidemics in Malaysia, Singapore, and Western Australia. J Virol (2001) 3.80
Epidemiologic and virologic investigation of hand, foot, and mouth disease, southern Vietnam, 2005. Emerg Infect Dis (2007) 3.79
Scavenger receptor B2 is a cellular receptor for enterovirus 71. Nat Med (2009) 3.20
Molecular epidemiology of human enterovirus 71 strains and recent outbreaks in the Asia-Pacific region: comparative analysis of the VP1 and VP4 genes. Emerg Infect Dis (2003) 2.98
Human P-selectin glycoprotein ligand-1 is a functional receptor for enterovirus 71. Nat Med (2009) 2.73
Sentinel surveillance for human enterovirus 71 in Sarawak, Malaysia: lessons from the first 7 years. BMC Public Health (2006) 2.57
Evolutionary genetics of human enterovirus 71: origin, population dynamics, natural selection, and seasonal periodicity of the VP1 gene. J Virol (2010) 2.50
The persistent circulation of enterovirus 71 in People's Republic of China: causing emerging nationwide epidemics since 2008. PLoS One (2011) 1.96
Seroepidemiology of human enterovirus 71, Singapore. Emerg Infect Dis (2002) 1.81
Crystal structure of human enterovirus 71. Science (2012) 1.79
Retrospective seroepidemiology indicated that human enterovirus 71 and coxsackievirus A16 circulated wildly in central and southern China before large-scale outbreaks from 2008. Virol J (2010) 1.76
Hand, foot and mouth disease: seroprevalence of Coxsackie A16 and Enterovirus 71 in Germany. Med Microbiol Immunol (2009) 1.65
Human enterovirus 71 epidemics: what's next? Emerg Health Threats J (2013) 1.54
The enterovirus 71 A-particle forms a gateway to allow genome release: a cryoEM study of picornavirus uncoating. PLoS Pathog (2013) 1.52
Annexin II binds to capsid protein VP1 of enterovirus 71 and enhances viral infectivity. J Virol (2011) 1.44
Incorrect identification of recent Asian strains of Coxsackievirus A16 as human enterovirus 71: improved primers for the specific detection of human enterovirus 71 by RT PCR. BMC Infect Dis (2004) 1.39
Formaldehyde-inactivated whole-virus vaccine protects a murine model of enterovirus 71 encephalomyelitis against disease. J Virol (2010) 1.38
Molecular determinants of enterovirus 71 viral entry: cleft around GLN-172 on VP1 protein interacts with variable region on scavenge receptor B 2. J Biol Chem (2012) 1.33
Distribution of enteroviruses in hospitalized children with hand, foot and mouth disease and relationship between pathogens and nervous system complications. Virol J (2012) 1.30
Identification of a human SCARB2 region that is important for enterovirus 71 binding and infection. J Virol (2011) 1.26
Clinical and etiological characteristics of enterovirus 71-related diseases during a recent 2-year period in Korea. J Clin Microbiol (2010) 1.25
Adaptive mutations in the genomes of enterovirus 71 strains following infection of mouse cells expressing human P-selectin glycoprotein ligand-1. J Gen Virol (2010) 1.25
Evaluation of different clinical sample types in diagnosis of human enterovirus 71-associated hand-foot-and-mouth disease. J Clin Microbiol (2007) 1.22
Sustained high levels of interleukin-6 contribute to the pathogenesis of enterovirus 71 in a neonate mouse model. J Virol (2011) 1.22
Time series analysis of hand-foot-mouth disease hospitalization in Zhengzhou: establishment of forecasting models using climate variables as predictors. PLoS One (2014) 1.15
Functional comparison of SCARB2 and PSGL1 as receptors for enterovirus 71. J Virol (2013) 1.14
Co-circulation and genomic recombination of coxsackievirus A16 and enterovirus 71 during a large outbreak of hand, foot, and mouth disease in Central China. PLoS One (2014) 1.13
Study on risk factors for severe hand, foot and mouth disease in China. PLoS One (2014) 1.13
Epidemiological and clinical characteristics of children who died from hand, foot and mouth disease in Vietnam, 2011. BMC Infect Dis (2014) 1.12
Combining multiplex reverse transcription-PCR and a diagnostic microarray to detect and differentiate enterovirus 71 and coxsackievirus A16. J Clin Microbiol (2006) 1.12
Fatal coxsackievirus A-16 pneumonitis in adult. Emerg Infect Dis (2007) 1.11
Seroepidemiology of human enterovirus71 and coxsackievirusA16 among children in Guangdong province, China. BMC Infect Dis (2013) 1.08
Neutralizing antibody response in the patients with hand, foot and mouth disease to enterovirus 71 and its clinical implications. Virol J (2011) 1.08
Incidence rates of enterovirus 71 infections in young children during a nationwide epidemic in Taiwan, 2008-09. PLoS Negl Trop Dis (2012) 1.06
Rhombencephalitis and coxsackievirus A16. Emerg Infect Dis (2009) 1.05
Enterovirus 71 infection: An experience in Korea, 2009. Korean J Pediatr (2010) 1.05
Prevalence of multiple enteroviruses associated with hand, foot, and mouth disease in Shijiazhuang City, Hebei province, China: outbreaks of coxsackieviruses a10 and b3. PLoS One (2014) 1.05
Comparative analysis of the immunogenicity and protective effects of inactivated EV71 vaccines in mice. PLoS One (2012) 1.02
Cell surface vimentin is an attachment receptor for enterovirus 71. J Virol (2014) 1.02
MRI and associated clinical characteristics of EV71-induced brainstem encephalitis in children with hand-foot-mouth disease. Neuroradiology (2011) 1.01
Prevalence and characterization of enterovirus infections among pediatric patients with hand foot mouth disease, herpangina and influenza like illness in Thailand, 2012. PLoS One (2014) 1.00
Lycorine reduces mortality of human enterovirus 71-infected mice by inhibiting virus replication. Virol J (2011) 0.99
Hand, Foot, and Mouth Disease in China: Modeling Epidemic Dynamics of Enterovirus Serotypes and Implications for Vaccination. PLoS Med (2016) 0.99
Structure of human enterovirus 71 in complex with a capsid-binding inhibitor. Proc Natl Acad Sci U S A (2013) 0.98
The cytokine and chemokine profiles in patients with hand, foot and mouth disease of different severities in Shanghai, China, 2010. PLoS Negl Trop Dis (2013) 0.94
The Epidemiological Study of Coxsackievirus A6 revealing Hand, Foot and Mouth Disease Epidemic patterns in Guangdong, China. Sci Rep (2015) 0.94
Analysis of the Th1/Th2 reaction in the immune response induced by EV71 inactivated vaccine in neonatal rhesus monkeys. J Clin Immunol (2012) 0.93
Display of VP1 on the surface of baculovirus and its immunogenicity against heterologous human enterovirus 71 strains in mice. PLoS One (2011) 0.93
Accuracy of diagnostic methods and surveillance sensitivity for human enterovirus, South Korea, 1999-2011. Emerg Infect Dis (2013) 0.93
Establishment of cell lines with increased susceptibility to EV71/CA16 by stable overexpression of SCARB2. Virol J (2013) 0.92
Antibody dependent enhancement infection of enterovirus 71 in vitro and in vivo. Virol J (2011) 0.92
Modeling and preventive measures of hand, foot and mouth disease (HFMD) in China. Int J Environ Res Public Health (2014) 0.92
Protection against lethal enterovirus 71 challenge in mice by a recombinant vaccine candidate containing a broadly cross-neutralizing epitope within the VP2 EF loop. Theranostics (2014) 0.91
Enterovirus 71-associated hand, foot and mouth diseases with neurologic symptoms, a university hospital experience in Korea, 2009. Korean J Pediatr (2010) 0.89
Immunogenicity, safety, and lot consistency of a novel inactivated enterovirus 71 vaccine in Chinese children aged 6 to 59 months. Clin Vaccine Immunol (2013) 0.87
Occurrence of hand-foot-and-mouth disease pathogens in domestic sewage and secondary effluent in Xi'an, China. Microbes Environ (2012) 0.86
Structure determination of enterovirus 71. Acta Crystallogr D Biol Crystallogr (2012) 0.86
Scavenger receptor b2 as a receptor for hand, foot, and mouth disease and severe neurological diseases. Front Microbiol (2012) 0.85
Epidemiological Research on Hand, Foot, and Mouth Disease in Mainland China. Viruses (2015) 0.85
The gene expression profile of peripheral blood mononuclear cells from EV71-infected rhesus infants and the significance in viral pathogenesis. PLoS One (2014) 0.84
Cardiac complications of enterovirus rhombencephalitis. Arch Dis Child (2004) 0.83
A novel recombinant lineage's contribution to the outbreak of coxsackievirus A6-associated hand, foot and mouth disease in Shanghai, China, 2012-2013. Sci Rep (2015) 0.83
Receptors for enterovirus 71. Emerg Microbes Infect (2014) 0.83
Identification of luteolin as enterovirus 71 and coxsackievirus A16 inhibitors through reporter viruses and cell viability-based screening. Viruses (2014) 0.83
Effect of Meteorological and Geographical Factors on the Epidemics of Hand, Foot, and Mouth Disease in Island-Type Territory, East Asia. Biomed Res Int (2015) 0.82
Workshop on use of intravenous immunoglobulin in hand, foot and mouth disease in Southeast Asia. Emerg Infect Dis (2015) 0.82
Enterovirus 71 infection in children with hand, foot, and mouth disease in Shanghai, China: epidemiology, clinical feature and diagnosis. Virol J (2015) 0.82
Animal models of enterovirus 71 infection: applications and limitations. J Biomed Sci (2014) 0.82
The Current Status of the Disease Caused by Enterovirus 71 Infections: Epidemiology, Pathogenesis, Molecular Epidemiology, and Vaccine Development. Int J Environ Res Public Health (2016) 0.81
Cardiac Dysfunction After Neurologic Injury: What Do We Know and Where Are We Going? Chest (2015) 0.81
Clinical features of severe cases of hand, foot and mouth disease with EV71 virus infection in China. Arch Med Sci (2014) 0.81
The Effects of Weather Factors on Hand, Foot and Mouth Disease in Beijing. Sci Rep (2016) 0.81
Broad protection with an inactivated vaccine against primary-isolated lethal enterovirus 71 infection in newborn mice. BMC Microbiol (2015) 0.81
Enterovirus 71 mediates cell cycle arrest in S phase through non-structural protein 3D. Cell Cycle (2015) 0.80
The enterovirus 71 procapsid binds neutralizing antibodies and rescues virus infection in vitro. J Virol (2014) 0.80
Inferring nonneutral evolution from contrasting patterns of polymorphisms and divergences in different protein coding regions of enterovirus 71 circulating in Taiwan during 1998-2003. BMC Evol Biol (2010) 0.80
Virological investigation of hand, foot, and mouth disease in a tertiary care center in South India. J Glob Infect Dis (2012) 0.80
Molecular epidemiology of coxsackievirus A6 associated with outbreaks of hand, foot, and mouth disease in Tianjin, China, in 2013. Arch Virol (2015) 0.80
TLR3 signaling in macrophages is indispensable for the protective immunity of invariant natural killer T cells against enterovirus 71 infection. PLoS Pathog (2015) 0.80
Enterovirus 71 infection causes severe pulmonary lesions in gerbils, meriones unguiculatus, which can be prevented by passive immunization with specific antisera. PLoS One (2015) 0.80
Comparison of heart failure in children with enterovirus 71 rhombencephalitis and cats with norepinephrine cardiotoxicity. Pediatr Cardiol (2006) 0.80
Necrotizing myositis causes restrictive hypoventilation in a mouse model for human enterovirus 71 infection. Virol J (2013) 0.80
Coxsackievirus A16 infection induces neural cell and non-neural cell apoptosis in vitro. PLoS One (2014) 0.80
Risk factors for severe hand foot mouth disease in Singapore: a case control study. BMC Infect Dis (2015) 0.79
Paroxysmal supraventricular tachycardia in an infant with hand, foot, and mouth disease. Ann Dermatol (2012) 0.79
Seroprevalence of Enterovirus 71 Antibody Among Children in China: A Systematic Review and Meta-analysis. Pediatr Infect Dis J (2015) 0.79
Coxsackievirus B4 myocarditis and meningoencephalitis in newborn twins. Neuropathology (2014) 0.79
Development of a sensitive and specific epitope-blocking ELISA for universal detection of antibodies to human enterovirus 71 strains. PLoS One (2013) 0.79
EV71-infected CD14(+) cells modulate the immune activity of T lymphocytes in rhesus monkeys. Emerg Microbes Infect (2013) 0.79
Complete genome sequencing and analysis of six enterovirus 71 strains with different clinical phenotypes. Virol J (2013) 0.78
The role of Misshapen NCK-related kinase (MINK), a novel Ste20 family kinase, in the IRES-mediated protein translation of human enterovirus 71. PLoS Pathog (2015) 0.78
The immunogenicity and protection effect of the BPL-inactivated CA16 vaccine in different animal systems. Hum Vaccin Immunother (2014) 0.78
Hand, Foot, and Mouth Disease in China: Critical Community Size and Spatial Vaccination Strategies. Sci Rep (2016) 0.78
Enterovirus 71 infection and neurological complications. Korean J Pediatr (2016) 0.78
A Broadly Cross-protective Vaccine Presenting the Neighboring Epitopes within the VP1 GH Loop and VP2 EF Loop of Enterovirus 71. Sci Rep (2015) 0.78
In vivo time-related evaluation of a therapeutic neutralization monoclonal antibody against lethal enterovirus 71 infection in a mouse model. PLoS One (2014) 0.78
Epidemiology and virologic investigation of human enterovirus 71 infection in the Republic of Korea from 2007 to 2012: a nationwide cross-sectional study. BMC Infect Dis (2016) 0.76
Nipah virus: a recently emergent deadly paramyxovirus. Science (2000) 9.39
Derivation and prospective validation of a simple index for prediction of cardiac risk of major noncardiac surgery. Circulation (1999) 8.17
Bronchiolitis-associated hospitalizations among US children, 1980-1996. JAMA (1999) 8.07
Molecular evolution of the human enteroviruses: correlation of serotype with VP1 sequence and application to picornavirus classification. J Virol (1999) 7.79
Pattern recognition receptors TLR4 and CD14 mediate response to respiratory syncytial virus. Nat Immunol (2000) 7.78
Hantavirus pulmonary syndrome: a clinical description of 17 patients with a newly recognized disease. The Hantavirus Study Group. N Engl J Med (1994) 7.61
The progression from hypertension to congestive heart failure. JAMA (1996) 7.56
The reemergence of Ebola hemorrhagic fever, Democratic Republic of the Congo, 1995. Commission de Lutte contre les Epidémies à Kikwit. J Infect Dis (1999) 7.39
A mouse model for the evaluation of pathogenesis and immunity to influenza A (H5N1) viruses isolated from humans. J Virol (1999) 6.03
Diagnosis of growth-hormone deficiency in adults. Lancet (1994) 5.93
Antigenic characterization of respiratory syncytial virus strains with monoclonal antibodies. J Infect Dis (1985) 5.91
Fatal encephalitis due to Nipah virus among pig-farmers in Malaysia. Lancet (1999) 5.14
Typing of human enteroviruses by partial sequencing of VP1. J Clin Microbiol (1999) 5.08
Molecular epidemiology and evolution of enterovirus 71 strains isolated from 1970 to 1998. J Virol (1999) 4.72
A clinical trial comparing three antithrombotic-drug regimens after coronary-artery stenting. Stent Anticoagulation Restenosis Study Investigators. N Engl J Med (1998) 4.68
Experimental inoculation of plants and animals with Ebola virus. Emerg Infect Dis (1997) 4.03
Geographic distribution of wild poliovirus type 1 genotypes. Virology (1987) 4.03
Comparison of classic and molecular approaches for the identification of untypeable enteroviruses. J Clin Microbiol (2000) 3.99
Epidemic leptospirosis associated with pulmonary hemorrhage-Nicaragua, 1995. J Infect Dis (1998) 3.97
Depletion of lymphocytes and diminished cytokine production in mice infected with a highly virulent influenza A (H5N1) virus isolated from humans. J Virol (2000) 3.88
Protease required for processing picornaviral coat protein resides in the viral replicase gene. J Virol (1979) 3.70
Beyond viruses: clinical profiles and etiologies associated with encephalitis. Clin Infect Dis (2006) 3.59
Leptospirosis associated with outbreak of acute febrile illness and pulmonary haemorrhage, Nicaragua, 1995. The Epidemic Working Group at Ministry of Health in Nicaragua. Lancet (1996) 3.34
Enterovirus 71 infections and neurologic disease--United States, 1977-1991. J Infect Dis (1994) 3.31
The epidemiology of enteric caliciviruses from humans: a reassessment using new diagnostics. J Infect Dis (2000) 3.29
Immunization for Ebola virus infection. Nat Med (1998) 3.27
Outbreak of Nipah-virus infection among abattoir workers in Singapore. Lancet (1999) 3.24
Fever and multisystem organ failure associated with 17D-204 yellow fever vaccination: a report of four cases. Lancet (2001) 3.21
Circulation patterns of genetically distinct group A and B strains of human respiratory syncytial virus in a community. J Gen Virol (1998) 3.06
Temporal and geographic patterns of isolates of nonpolio enterovirus in the United States, 1970-1983. J Infect Dis (1986) 3.01
Dendritic cell maturation is required for the cross-tolerization of CD8+ T cells. Nat Immunol (2001) 2.98
Complete nucleotide sequence of enterovirus 71 is distinct from poliovirus. Virus Res (1995) 2.98
Cost-effectiveness analysis of a rotavirus immunization program for the United States. JAMA (1998) 2.86
Cardiac T2* magnetic resonance for prediction of cardiac complications in thalassemia major. Circulation (2009) 2.85
Preparation and characterization of encephalomyocarditis (EMC) virus. Methods Enzymol (1981) 2.81
Markedly elevated levels of interferon (IFN)-gamma, IFN-alpha, interleukin (IL)-2, IL-10, and tumor necrosis factor-alpha associated with fatal Ebola virus infection. J Infect Dis (1999) 2.76
Stent thrombosis in the modern era: a pooled analysis of multicenter coronary stent clinical trials. Circulation (2001) 2.73
A role for apolipoprotein E, apolipoprotein A-I, and low density lipoprotein receptors in cholesterol transport during regeneration and remyelination of the rat sciatic nerve. J Clin Invest (1989) 2.71
Standardizing Chlamydia pneumoniae assays: recommendations from the Centers for Disease Control and Prevention (USA) and the Laboratory Centre for Disease Control (Canada). Clin Infect Dis (2001) 2.71
Involvement of toll-like receptor 4 in innate immunity to respiratory syncytial virus. J Virol (2001) 2.70
Bronchiolitis-associated mortality and estimates of respiratory syncytial virus-associated deaths among US children, 1979-1997. J Infect Dis (2000) 2.68
Hantavirus pulmonary syndrome: the first 100 US cases. J Infect Dis (1996) 2.64
Outbreak of paralytic poliomyelitis in Oman: evidence for widespread transmission among fully vaccinated children. Lancet (1991) 2.64
Molecular characterization of Nipah virus, a newly emergent paramyxovirus. Virology (2000) 2.63
Case-control study of risk factors for human infection with a new zoonotic paramyxovirus, Nipah virus, during a 1998-1999 outbreak of severe encephalitis in Malaysia. J Infect Dis (2000) 2.57
Self-assembled B19 parvovirus capsids, produced in a baculovirus system, are antigenically and immunogenically similar to native virions. Proc Natl Acad Sci U S A (1991) 2.55
Respiratory syncytial virus is an important cause of community-acquired lower respiratory infection among hospitalized adults. J Infect Dis (1996) 2.55
Epidemiology of poliomyelitis in the United States one decade after the last reported case of indigenous wild virus-associated disease. Clin Infect Dis (1992) 2.55
Respiratory syncytial virus pneumonia among the elderly: an assessment of disease burden. J Infect Dis (1999) 2.44
Effect of matrix metalloproteinases activity on outflow in perfused human organ culture. Invest Ophthalmol Vis Sci (1998) 2.43
Occurrence of groups A and B of respiratory syncytial virus over 15 years: associated epidemiologic and clinical characteristics in hospitalized and ambulatory children. J Infect Dis (1990) 2.41
Detection and identification of vaccine-related polioviruses by the polymerase chain reaction. Virus Res (1991) 2.35
Trial of a supplemental dose of four poliovirus vaccines. N Engl J Med (2000) 2.35
Genotype-specific in vitro amplification of sequences of the wild type 3 polioviruses from Mexico and Guatemala. Virus Res (1992) 2.33
Protein processing map of poliovirus. J Virol (1984) 2.33
Detection of Norwalk virus antibodies and antigen with a biotin-avidin immunoassay. J Clin Microbiol (1985) 2.28
A reassortant bunyavirus isolated from acute hemorrhagic fever cases in Kenya and Somalia. Virology (2001) 2.28
Concurrent circulation of antigenically distinct strains of respiratory syncytial virus during community outbreaks. J Infect Dis (1986) 2.26
Immunogenicity of a supplemental dose of oral versus inactivated poliovirus vaccine. Lancet (1993) 2.24
Prolonged replication of a type 1 vaccine-derived poliovirus in an immunodeficient patient. J Clin Microbiol (1998) 2.24
Group-specific identification of polioviruses by PCR using primers containing mixed-base or deoxyinosine residue at positions of codon degeneracy. J Clin Microbiol (1996) 2.23
CX3C chemokine mimicry by respiratory syncytial virus G glycoprotein. Nat Immunol (2001) 2.21
Detection and characterization of novel rotavirus strains in the United States. J Clin Microbiol (1998) 2.16
Duration of poliovirus excretion and its implications for acute flaccid paralysis surveillance: a review of the literature. J Infect Dis (1997) 2.16
Genetic diversity of the attachment protein of subgroup B respiratory syncytial viruses. J Virol (1991) 2.14
Circulation patterns of group A and B human respiratory syncytial virus genotypes in 5 communities in North America. J Infect Dis (2000) 2.13
Validation of a rapid method for detection of M. tuberculosis resistance to isoniazid and rifampin in Lima, Peru. Int J Tuberc Lung Dis (2005) 2.09
Isolation of the causative agent of hantavirus pulmonary syndrome. Am J Trop Med Hyg (1994) 2.07
Hidden mortality attributable to Rocky Mountain spotted fever: immunohistochemical detection of fatal, serologically unconfirmed disease. J Infect Dis (1999) 2.05
Fatal encephalitis and myocarditis in young domestic geese (Anser anser domesticus) caused by West Nile virus. Emerg Infect Dis (2001) 2.03
Risk factors for West Nile virus infection and meningoencephalitis, Romania, 1996. J Infect Dis (1999) 2.03
A cohort study of health care workers to assess nosocomial transmissibility of Nipah virus, Malaysia, 1999. J Infect Dis (2001) 2.02
Chronic parvovirus B19 infection and systemic necrotising vasculitis: opportunistic infection or aetiological agent? Lancet (1994) 2.00
Hantavirus pulmonary syndrome in the United States: a pathological description of a disease caused by a new agent. Hum Pathol (1995) 2.00
Myocardial iron loading in patients with thalassemia major on deferoxamine chelation. J Cardiovasc Magn Reson (2006) 1.97
Spotted fever in Brazil: a seroepidemiological study and description of clinical cases in an endemic area in the state of São Paulo. Am J Trop Med Hyg (2001) 1.95
Seroprevalence of antibody against poliovirus in inner-city preschool children. Implications for vaccination policy in the United States. JAMA (1996) 1.93
Changes in three of the four coat proteins of oral polio vaccine strain derived from type 1 poliovirus. J Virol (1980) 1.91
Adenoviruses from patients with AIDS: a plethora of serotypes and a description of five new serotypes of subgenus D (types 43-47). J Infect Dis (1988) 1.87
Characterization of nontypeable rotavirus strains from the United States: identification of a new rotavirus reassortant (P2A[6],G12) and rare P3[9] strains related to bovine rotaviruses. Virology (2002) 1.85
Microneutralization test for respiratory syncytial virus based on an enzyme immunoassay. J Clin Microbiol (1985) 1.84
Crystal structure of the type-I interleukin-1 receptor complexed with interleukin-1beta. Nature (1997) 1.83
Failure to detect enterovirus in the spinal cord of ALS patients using a sensitive RT-PCR method. Neurology (2004) 1.83
Comparative study of five methods for intratypic differentiation of polioviruses. J Clin Microbiol (1995) 1.83
Occupational risk of human parvovirus B19 infection for school and day-care personnel during an outbreak of erythema infectiosum. JAMA (1990) 1.79
Tissue Doppler echocardiography in patients with thalassaemia detects early myocardial dysfunction related to myocardial iron overload. Eur Heart J (2003) 1.79
New-onset juvenile dermatomyositis: comparisons with a healthy cohort and children with juvenile rheumatoid arthritis. Arthritis Rheum (1997) 1.78
Picornaviral VPg sequences are contained in the replicase precursor. J Virol (1980) 1.77
Bronchiolitis-associated hospitalizations among American Indian and Alaska Native children. Pediatr Infect Dis J (2000) 1.75
Analyses of homologous rotavirus infection in the mouse model. Virology (1995) 1.75